CoChat
Sign Up
Cited by 275Nonmelanoma Skin Cancer StudiesPhotodynamic Therapy Research StudiesHead and Neck Cancer Studies

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Five-Year Follow-up of a Randomized, Prospective Trial of Topical Methyl Aminolevulinate Photodynamic Therapy vs Surgery for Nodular Basal Cell Carcinoma

Rhodes, Lesley E., de Rie, Menno A., Leifsdottir, Ragna, Yu, Raymond C., Bachmann, Ingeborg, Goulden, Victoria, Wong, Gavin A. E., Richard, Marie-Aleth, Anstey, Alex, Wolf, Peter·2007·Archives of Dermatology
DOI 10.1001/archderm.143.9.1131
Open this paper in CoChat — free account

Abstract

OBJECTIVE: To compare 5-year lesion recurrence rates in primary nodular basal cell carcinoma treated with topical methyl aminolevulinate photodynamic therapy (PDT) or simple excision surgery. DESIGN: Prospective, randomized, multicenter study. SETTING: University hospital dermatology departments. PATIENTS: A total of 97 patients, 50 with 53 lesions treated with methyl aminolevulinate PDT and 47 with 52 lesions treated by excision surgery, were included in the per protocol analysis. Of the lesions treated with methyl aminolevulinate PDT and surgery, 49 and 52, respectively, showed complete clinical response at 3 months after treatment and were observed for long-term outcome evaluation. INTERVENTIONS: Topical methyl aminolevulinate cream, 160 mg/g, applied for 3 hours before illumination (75 J/cm(2) of red light at 570 to 670 nm) on 2 or 4 occasions (12 [23%] of 53 lesions); or excision surgery. MAIN OUTCOME MEASURES: Histologically confirmed lesion recurrence, sustained lesion complete response rate (time-to-event analysis), and investigator assessment of cosmetic outcome, 5 years after the last treatment. RESULTS: At 5 years, recurrence was documented in 7 (14%) of 49 lesions (95% confidence interval [CI], 6%-27%) treated with methyl aminolevulinate PDT vs 2 (4%) of 52 lesions (95% CI, 1%-13%) treated with excision surgery (P = .09). Estimated sustained lesion complete response rates were 76% (95% CI, 59%-87%) and 96% (95% CI, 84%-99%), respectively (P = .01). More patients treated with methyl aminolevulinate PDT than surgery had an excellent or good cosmetic outcome: 27 (87%) of 31 patients (95% CI, 70%-96%) vs 19 (54%) of 35 patients (95% CI, 37%-71%) (P = .007). CONCLUSIONS: Long-term follow-up indicates superior efficacy of surgery to methyl aminolevulinate PDT in nodular basal cell carcinoma. However, methyl aminolevulinate PDT is also an effective treatment for this indication and exhibits a more favorable cosmetic outcome.

Overview

Integrity signals

Registry

Crossref · 10.1001/archderm.143.9.1131

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 13 references

Cited by

Sorted by citations

Items 101–200 of 274

Related

See all

Metadata

Authors
Rhodes, L. E., de Rie, M. A., Leifsdottir, R., Yu, R. C., Bachmann, I., Goulden, V., Wong, G. A. E., Richard, M.-A., Anstey, A., & Wolf, P.
Affiliations
University of Manchester (GB)
ORCID
Venue
Archives of Dermatology
Publisher
American Medical Association (AMA)
Published
2007-09-01
Volume
143
Issue
9
Pages
1131-6
ISSN
0003-987X (ISSN-L)
DOI
10.1001/archderm.143.9.1131
OpenAlex
W2026103783
Cited by
275
References
13
Citations by year
2026: 5 · 2025: 8 · 2024: 10 · 2023: 9 · 2022: 13 · 2021: 8 · 2020: 17 · 2019: 16 · 2018: 19 · 2017: 9 · 2016: 17 · 2015: 18 · 2014: 13 · 2013: 18 · 2012: 18
FWCI
11.47
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Nonmelanoma Skin Cancer Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
Keywords
surgical excision, lesion recurrence, complete response rate, cosmetic outcome, long-term follow-up, skin cancer treatment, red light illumination, per-protocol analysis, histological recurrence, treatment efficacy comparison, patient satisfaction with treatment outcomes
MeSH terms
Administration, Topical, Aged, Aged, 80 and over, Aminolevulinic Acid, Basal Cell Carcinoma, Female, Follow-Up Studies, Humans, Male, Neoplasm Recurrence, Local, Ointments, Photochemotherapy, Skin Neoplasms, Photosensitizing Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review